These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 26556463)
1. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss. Lee JB; Choi SJ Otolaryngol Head Neck Surg; 2016 Feb; 154(2):328-34. PubMed ID: 26556463 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Suzuki H; Hashida K; Nguyen KH; Hohchi N; Katoh A; Koizumi H; Ohbuchi T Laryngoscope; 2012 May; 122(5):1154-7. PubMed ID: 22447636 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Lim HJ; Kim YT; Choi SJ; Lee JB; Park HY; Park K; Choung YH Otolaryngol Head Neck Surg; 2013 Jan; 148(1):121-7. PubMed ID: 23077155 [TBL] [Abstract][Full Text] [Related]
4. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Lee JB; Choi SJ; Park K; Park HY; Choo OS; Choung YH Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):833-9. PubMed ID: 21221620 [TBL] [Abstract][Full Text] [Related]
5. Potential benefits of salvage intratympanic dexamethasone injection in profound idiopathic sudden sensorineural hearing loss. Choi JW; Lee CK; Kim SB; Lee DY; Ko SC; Park KH; Choi SJ Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2219-2227. PubMed ID: 32296977 [TBL] [Abstract][Full Text] [Related]
6. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Gouveris H; Schuler-Schmidt W; Mewes T; Mann W Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Bae SC; Noh HI; Jun BC; Jeon EJ; Seo JH; Park SY; Kim JK; Lee DH; Oh JH; Park SN; Yeo SW Acta Otolaryngol; 2013 May; 133(5):428-33. PubMed ID: 23356871 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Intratympanic Steroid on Idiopathic Sudden Sensorineural Hearing Loss: An Analysis of Cases With Negative Prognostic Factors. Suzuki H; Kawaguchi R; Wakasugi T; Do BH; Kitamura T; Ohbuchi T Am J Audiol; 2019 Jun; 28(2):308-314. PubMed ID: 31046392 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss. Suzuki H; Wakasugi T; Kitamura T; Koizumi H; Do BH; Ohbuchi T Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622 [TBL] [Abstract][Full Text] [Related]
10. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Choung YH; Park K; Shin YR; Cho MJ Laryngoscope; 2006 May; 116(5):747-52. PubMed ID: 16652082 [TBL] [Abstract][Full Text] [Related]
11. Analysis of frequency loss as a prognostic factor in idiopathic sensorineural hearing loss. Jun HJ; Chang J; Im GJ; Kwon SY; Jung H; Choi J Acta Otolaryngol; 2012 Jun; 132(6):590-6. PubMed ID: 22497556 [TBL] [Abstract][Full Text] [Related]
13. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Fujimura T; Suzuki H; Shiomori T; Udaka T; Mori T Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):861-6. PubMed ID: 17340130 [TBL] [Abstract][Full Text] [Related]
14. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of combination therapy for idiopathic sudden sensorineural hearing loss. Jung da J; Park JH; Jang JH; Lee KY Laryngoscope; 2016 Aug; 126(8):1871-6. PubMed ID: 26972103 [TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygen therapy with short duration intratympanic steroid therapy for sudden hearing loss. Filipo R; Attanasio G; Viccaro M; Russo FY; Mancini P; Rocco M; Pietropaoli P; Covelli E Acta Otolaryngol; 2012 May; 132(5):475-81. PubMed ID: 22292673 [TBL] [Abstract][Full Text] [Related]
17. Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss. Covelli E; Altabaa K; Verillaud B; Camous D; Hautefort C; Barbara M; Herman P; Kania R Acta Otolaryngol; 2018 Nov; 138(11):966-971. PubMed ID: 30380957 [TBL] [Abstract][Full Text] [Related]
18. Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss. Tsai HT; Hsueh N; Huang CM; Lin HC Acta Otolaryngol; 2015 Aug; 135(8):786-90. PubMed ID: 25783847 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss. Sevil E; Bercin S; Muderris T; Gul F; Kiris M Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2419-26. PubMed ID: 26538427 [TBL] [Abstract][Full Text] [Related]
20. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss. Suzuki H; Koizumi H; Ohkubo J; Hohchi N; Ikezaki S; Kitamura T Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3101-7. PubMed ID: 26879994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]